Upstream Bio, Inc.
UPB
$25.01
-$3.97-13.70%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.75M | -39.97M | -27.27M | -21.24M | -15.99M |
| Total Depreciation and Amortization | 46.00K | 42.00K | 43.00K | 49.00K | 14.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.58M | 1.75M | 1.03M | 2.90M | 1.30M |
| Change in Net Operating Assets | 8.88M | -1.07M | -14.97M | -1.32M | 717.00K |
| Cash from Operations | -22.24M | -39.24M | -41.17M | -19.61M | -13.96M |
| Capital Expenditure | -64.00K | -47.00K | -- | -185.00K | -326.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 48.25M | 12.82M | -213.38M | 42.09M | 1.74M |
| Cash from Investing | 48.19M | 12.77M | -213.38M | 41.91M | 1.41M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 760.00K | 612.00K | -- | 272.75M | 19.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 75.00K | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -34.00K | -2.18M | -1.66M |
| Cash from Financing | 760.00K | 612.00K | -34.00K | 270.65M | -1.64M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.71M | -25.85M | -254.58M | 292.94M | -14.19M |